Papillary
By far the most common type, making up roughly 8 in 10 thyroid cancers. Slow-growing and well differentiated, it carries an excellent prognosis. Read more on our papillary thyroid cancer page.
Medically reviewed by Dr. Owais Mohammed, Medical Oncologist, MBBS · MD · Last reviewed June 2026
When thyroid cancer is diagnosed, one of the first things your report describes is whether it is differentiated or undifferentiated. This simply describes how closely the cancer cells still resemble normal thyroid tissue — and it shapes the prognosis and the treatment plan. Understanding the difference helps you take the next step calmly.
The thyroid is a small, butterfly-shaped gland at the base of the neck that controls how your body uses energy. When thyroid cancer is found, pathologists look at the cancer cells under a microscope and describe how closely they still resemble normal thyroid tissue. That single observation is what the words differentiated and undifferentiated describe.
Differentiated thyroid cancer (DTC) means the cells still look and behave much like normal thyroid cells. The term well differentiated thyroid cancer describes exactly this — cells that keep their normal features. Because of that, these cancers tend to grow slowly, can still take up iodine, and respond very well to treatment. They make up the large majority of all thyroid cancers.
Undifferentiated thyroid cancer — also called anaplastic thyroid cancer — means the cells have lost the features of normal thyroid tissue. The undifferentiated meaning here is important: cells this abnormal grow quickly and behave aggressively, so this type is rare but needs urgent, specialist care.
If you have just been given one of these labels, the most important thing to know is that the type guides the plan. A clear diagnosis is the start of a well-mapped pathway — not a reason to panic. We walk this journey with you, one step at a time.
The large majority of thyroid cancers are differentiated — papillary alone accounts for roughly 8 in 10 cases — while undifferentiated (anaplastic) cancer is rare, making up only a small fraction of thyroid cancers. (Source: NCCN Clinical Practice Guidelines in Oncology — Thyroid Carcinoma; American Cancer Society.)
Three main types of thyroid cancer are differentiated. All start in the follicular cells of the thyroid, grow slowly, and usually respond well to surgery and, where needed, radioactive iodine. Your pathology report will name which one you have.
By far the most common type, making up roughly 8 in 10 thyroid cancers. Slow-growing and well differentiated, it carries an excellent prognosis. Read more on our papillary thyroid cancer page.
The next most common differentiated type. It is also well differentiated and slow-growing, and usually responds well to surgery and radioactive iodine, with a favourable outlook.
A less common variant counted as differentiated. It is treated along similar lines, though it is watched a little more closely and may take up iodine less readily than other types.
Set apart from the above. Its cells have lost their normal features, so it grows quickly and no longer takes up iodine. Rare, but it needs urgent, coordinated specialist care.
This is not just a label on a report — it is one of the most important early facts about your cancer, because it shapes both the likely outlook and the treatment plan.
It shapes the prognosis. Well differentiated thyroid cancers grow slowly and respond well to treatment, so the great majority of patients do very well. Undifferentiated cancer is more serious and is managed with greater urgency.
It shapes the treatment. Because differentiated cells still take up iodine, radioactive iodine (RAI) therapy can be used after surgery. Undifferentiated cancer does not take up iodine, so its treatment combines surgery, radiation and systemic therapy instead.
Because the two are managed so differently, confirming which category you have is essential before any treatment begins. Speak to a CION thyroid cancer specialist to understand what your own report means.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Differentiated or undifferentiated, the right plan is the one made for you, by a team. We give you a 45-minute consultation, a tumour-board review, and no unnecessary tests.
This table summarises the main differences. It is a general guide; your own outlook and plan are confirmed by a tumour board after reviewing your reports.
| Differentiated (DTC) | Undifferentiated (Anaplastic) | |
|---|---|---|
| What the cells look like | Still resemble normal thyroid cells — "well differentiated" | Have lost the features of normal thyroid tissue |
| Main types | Papillary, follicular, Hürthle cell | Anaplastic thyroid cancer |
| How common | The large majority of thyroid cancers | Rare — a small fraction of thyroid cancers |
| How it grows | Usually slow-growing | Fast-growing and aggressive |
| Takes up iodine? | Yes — so radioactive iodine (RAI) can be used | Usually no — RAI is not effective |
| Main treatments | Surgery, selective RAI, thyroid hormone tablets | Surgery where feasible, radiation, systemic therapy |
| General outlook | Excellent — most patients do very well | More serious — needs urgent, coordinated care |
Because differentiated thyroid cancer cells still take up iodine, radioactive iodine (RAI) therapy can target leftover thyroid cells after surgery — a treatment that does not work for undifferentiated cancer, where the cells no longer absorb iodine. (Source: NCCN Clinical Practice Guidelines in Oncology — Thyroid Carcinoma.)
Because the two cancers behave so differently, they are treated differently. In every case at CION, a tumour board agrees the plan, so treatment is matched precisely to the type of cancer you have.
The main treatment for differentiated cancer — a lobectomy or total thyroidectomy. Surgery is also used for undifferentiated cancer where the tumour can be safely removed.
Used selectively for differentiated cancer, because those cells still take up iodine. It is not effective for undifferentiated cancer, whose cells no longer absorb iodine.
Central to treating undifferentiated cancer — radiation plus systemic therapy such as targeted or chemotherapy drugs, delivered urgently by a multidisciplinary team.
After surgery for differentiated cancer, most patients take a daily thyroid hormone tablet. At the right dose it replaces normal function and helps lower the chance of return.
The exact plan depends on the type, size and spread of your cancer — confirmed at thyroid cancer staging and agreed by a tumour board.
The category is decided by examining cells or tissue under a microscope — not by symptoms alone. Getting this right is the foundation of a correct treatment plan.
Ultrasound and FNAC. It usually begins with a neck ultrasound and a fine needle aspiration cytology (FNAC) — a quick outpatient test that samples cells from the thyroid nodule with a very thin needle. A pathologist then studies how closely the cells resemble normal thyroid tissue.
Confirmed after surgery, where needed. Sometimes the full picture, including the exact type, is confirmed once the whole specimen can be examined after surgery. At CION, the findings are reviewed by a tumour board before the plan is finalised.
If you already have a report, a free written second opinion can confirm the type and explain it clearly. Book a free review and take the next step with a team beside you.
If you want your diagnosis understood properly — and treated with exactly the right amount of care, no more and no less — here is what to expect at CION.
Whatever your report says, understanding it is the first step. Book a free consultation and walk the journey with a team beside you.
Real stories from patients who were newly diagnosed, got a clear plan, and walked the journey with our team.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified oncologist for guidance specific to your situation. This page is periodically reviewed and updated by CION's medical team in line with current clinical guidelines.
Browse our complete guide to thyroid cancer — types, symptoms, causes, tests, stages and treatment. Tap any topic to read more.